Michael J. Birrer, MD, PhD, on the role of maintenance therapy in newly diagnosed ovarian cancer

00:44 •

Michael J. Birrer, MD, PhD, on the role of maintenance therapy in newly diagnosed ovarian cancer

Related Videos

Charles Rudin, MD, PhD, shares the take home message regarding Keynote-604 for lung cancer treatment

Charles Rudin, MD, PhD, shares the take home message regarding Keynote-604 for lung cancer treatment

$Alti Rahman, MHA\MBA, CSSBB, offers advice to oncology practices in today's cancer care landscape$

Alti Rahman, MHA\MBA, CSSBB, offers advice to oncology practices in today's cancer care landscape

Sibel Blau, MD, tells us more about IQ Oncology

Sibel Blau, MD, tells us more about IQ Oncology

Johnetta Blakely, MD, reflects on the progress and innovation of community oncologists

Johnetta Blakely, MD, reflects on the progress and innovation of community oncologists

Kim N. Chi, MD, on what findings from the Phase III TITAN study mean for patients

Kim N. Chi, MD, on what findings from the Phase III TITAN study mean for patients

Hani Babiker, MD, describes the setting of FDA approval on tumor treatment fields

Hani Babiker, MD, describes the setting of FDA approval on tumor treatment fields

The impact of clinical pathways on quality cancer care as explained by Bruce Gould, MD

The impact of clinical pathways on quality cancer care as explained by Bruce Gould, MD

Sibel Blau, MD, speculates on the role of telehealth in cancer management

Sibel Blau, MD, speculates on the role of telehealth in cancer management

Ghassan Abou-Alfa, MD, explains how new agents in advanced HCC are being integrated into treatment

Ghassan Abou-Alfa, MD, explains how new agents in advanced HCC are being integrated into treatment

Banu Arun, MD, regarding the optimal setting for PARP inhibitors in breast cancer treatment

Banu Arun, MD, regarding the optimal setting for PARP inhibitors in breast cancer treatment

Alexander Spira, MD, PhD, FACP, on managing lung cancer patients in a community setting

Alexander Spira, MD, PhD, FACP, on managing lung cancer patients in a community setting

Matthew I. Milowsky, MD, explains how genomics are changing the way we treat bladder cancer subtypes

Matthew I. Milowsky, MD, explains how genomics are changing the way we treat bladder cancer subtypes

Erin Stevens, MD, on why oncologists should be concerned about sexual health in their patients

Erin Stevens, MD, on why oncologists should be concerned about sexual health in their patients

William Harwin, MD, tells us about the ancillary services his pracdtice has to help patients

William Harwin, MD, tells us about the ancillary services his pracdtice has to help patients

Una Hopkins, RN, regarding cancer survivorship resulting from expanded use of immune-oncology agents

Una Hopkins, RN, regarding cancer survivorship resulting from expanded use of immune-oncology agents

Jeff Vacirca, MD, talks about what his community oncology practice is doing to survive

Jeff Vacirca, MD, talks about what his community oncology practice is doing to survive

Michael Diaz, MD, on how community oncology is shaping the future of cancer care

Michael Diaz, MD, on how community oncology is shaping the future of cancer care

Debra Patt MD, expounds on the improvement of cancer care via artificial intelligence

Debra Patt MD, expounds on the improvement of cancer care via artificial intelligence

Brian Slomovitz, MD, elaborates on the role of immunotherapy in ovarian cancer

Brian Slomovitz, MD, elaborates on the role of immunotherapy in ovarian cancer

Lalan Wilfong, MD, shares knowledge on how to thrive in the rapidly evolving APM landscape

Lalan Wilfong, MD, shares knowledge on how to thrive in the rapidly evolving APM landscape